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Abstract
In order to evaluate probiotic strains applicable for the beneficial immunomodulation of the porcine gut 
(immunobiotics), we previously developed a porcine intestinal epitheliocyte cell line (PIE cells). Here, transcriptomic 
studies using PIE cells were performed considering that this information would be valuable for understanding the 
mechanisms involved in the protective activity of the immunobiotic strain Lactobacillus jensenii TL2937 against 
intestinal inflammatory damage in pigs. In addition, those studies would provide criteria for selecting biomarkers 
for the screening of new immunobiotic strains. We performed microarray analysis to investigate the transcriptomic 
response of PIE cells to the challenge with heat-stable enterotoxigenic Escherichia coli (ETEC) pathogen-associated 
molecular patterns (PAMPs) and, the changes induced by L. jensenii TL2937 in that response. The approach allowed 
us to obtain a global overview of the immune genes involved in the response of PIE cells to heat-stable ETEC 
PAMPs. We observed that L. jensenii TL2937 differently modulated gene expression in ETEC PAMPs-challenged 
PIE cells. Microarray and RT-PCR analysis indicated that the most remarkable changes in PIE cells transcriptomic 
profile after heat-stable ETEC PAMPs challenge were observed in chemokines, adhesion molecules, complement 
and coagulation cascades factors. In addition, an anti-inflammatory effect triggered by TL2937 strain in PIE cells 
was clearly demonstrated. The decrease in the expression of chemokines (CCL8, CXCL5, CXCL9, CXCL10, and 
CXCL11), complement (C1R, C1S, C3, and CFB), and coagulation factors (F3) by L. jensenii TL2937 supports 
our previous reports on the immunoregulatory effect of this strain. These results provided clues for the better 
understanding of the mechanism underlying host-immunobiotic interaction in the porcine host. The comprehensive 
transcriptomic profiles of PIE cells provided by our analyses successfully identified a group of genes, which could 
be used as prospective biomarkers for the screening and evaluation of new anti-inflammatory immunobiotics for 
the prevention of inflammatory intestinal disorders in pigs.
Keywords: porcine intestinal epitheliocytes, immunotranscriptomic response, ETEC, Lactobacillus jensenii TL2937, 
immunobiotic biomarkers
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1. Introduction
Enterotoxigenic Escherichia coli (ETEC) infects humans 
and several species of animals. In farm animals like pigs, 
ETEC infection results in reduced growth rate, increased 
mortality and economic loss. ETEC interacts with intestinal 
epithelial cells (IECs), colonises the small intestine and 
secretes enterotoxins inducing intestinal acute diarrhoea 
and inflammation (Ondrackova et al., 2012; Zhou et al., 
2012). In addition to its capacity to infect cells and induce 
damage through toxins, ETEC triggers inflammatory 
responses through other pathogen-associated molecular 
patterns (PAMPs), such as lipopolysaccharide (LPS) that 
significantly contribute to intestinal tissue injury during 
infections (Geens and Niewold, 2010; Zhou et al., 2012). 
Therefore, in order to protect pigs against ETEC without 
damaging host tissues it is important to generate both an 
adequate inflammatory response against the pathogen, and 
an efficient regulation of that response.
For several years, researchers have tested probiotics for 
decreasing pathogen load and ameliorating gastrointestinal 
disease symptoms in animals. The potential for positive 
manipulation of the porcine gut immune system through 
the introduction of beneficial microbes, described as 
immunobiotics, is currently a popular area of investigation 
(Villena and Kitazawa, 2014). In this regard, in order 
to identify potentially immunobiotic strains, we have 
developed and used several in vitro tests based in porcine 
cells including the clonal porcine intestinal epitheliocyte 
cell line (PIE cells) (Moue et al., 2008).
Our previous studies on expression profiles of Toll-like 
receptors (TLRs) in PIE cells have shown that TLR4 is 
strongly expressed in this cell line. In fact, PIE cells are 
able to increase chemokine and cytokine expressions in 
response to LPS stimulation. We have also demonstrated 
that treatment of PIE cells with Lactobacillus jensenii 
TL2937 is able to down-regulate the levels of interleukin 
(IL)-6, IL-8, and MCP-1 produced in response to heat-stable 
ETEC PAMPs or LPS challenges (Shimazu et al., 2012). 
Moreover, the effect of L. jensenii TL2937 on the expression 
of negative TLR regulators in PIE cells was also evaluated. 
The expression of SIGIRR, Tollip, A20, Bcl-3, MKP-1, and 
IRAK-M was studied, and it was found that MKP-1, A20, 
and Bcl-3 mRNA expression was up-regulated in PIE cells 
stimulated with this immunobiotic strain (Shimazu et al., 
2012). Our in vivo data concerning the immunoregulatory 
effect of L. jensenii TL2937 demonstrated that the 
administration of this immunobiotic bacterium improved 
immune health, growing performance, and productivity of 
piglets (Suda et al., 2014).
The evidence of a positive impact of immunobiotics on 
animal health has increased in the last years, however the 
mechanisms through which these beneficial microbes 
influence the animal host remain largely undefined. Various 
immune pathways have been implicated in the beneficial 
effects of immunobiotics in the porcine host (Tsukida et al., 
2016; Villena and Kitazawa, 2014), but few comprehensive 
studies have been undertaken, primarily due to lack of 
available tools. The recent development of specialised 
expression microarrays based on porcine genome sequence 
provides one such tool that can evaluate multiple pathways 
simultaneously (Schroyen and Tuggle, 2015).
We hypothesised that transcriptomic analyses using PIE cells 
could provide valuable data to understand the mechanisms 
involved in the protective activity of immunobiotics 
against intestinal inflammatory damage in the porcine 
host. In addition, this approach would provide criteria for 
selecting new biomarkers for the screening and selection 
of immunobiotics strains in PIE cells that can be used 
for the development of new immunologically functional 
feeds, which may help to prevent inflammatory intestinal 
disorders in pigs. The aim of this study was therefore to 
investigate: (1) the transcriptomic response of PIE cells 
to the challenge with heat-stable ETEC PAMPs; and (2) 
the changes in the transcriptomic profiles induced by the 
immunobiotic strain L. jensenii TL2937 in ETEC PAMPs-
challenged PIE cells. We also aimed to provide detailed 
interpretation of selected genes, which are prospective 
biomarkers for immunobiotics selection.
2. Materials and methods
Porcine intestinal epitheliocyte cells
PIE cells, which are non-transformed intestinal cultured 
cells originally derived from intestinal epithelia isolated 
from an unsuckled neonatal swine (Moue et al., 2008), 
were maintained in Dulbecco’s modified Eagle’s medium 
(DMEM) (Invitrogen Corporation, Carlsbad, CA, USA) 
supplemented with 10% foetal calf serum, 100 mg/ml 
penicillin, and 100 U/ml streptomycin at 37 °C in an 
atmosphere of 5% CO2. PIE cells grow rapidly and are well 
adapted to culture conditions even without transformation 
or immortalisation. However, the proliferative ability of PIE 
cells diminishes after 50 passages in culture. Therefore, 
we used PIE cells only between the 20th and 40th passages 
in these experiments (Shimazu et al., 2012; Tomosada et 
al., 2013).
Microorganisms
ETEC strain 987 (O9:H-:987 pilus+:heat-stable entero-
toxin+) was kindly provided by M. Nakazawa at the National 
Institute of Animal Health (Tsukuba, Japan) (Shimazu et 
al., 2012). ETEC cells were grown in tryptic soy broth (TSB; 
Becton, Dickinson and Company, San Jose, CA, USA) for 
24 h at 37 °C with shaking. After overnight incubation, the 
subcultures of bacteria were centrifuged at 5,000×g for 10 
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min at 4 °C, washed with phosphate-buffered saline (PBS), 
and heat killed (100 °C, 30 min). Heat-stable ETEC PAMPs 
were suspended in DMEM for use.
L. jensenii TL2937 and L. plantarum TL2766 were grown 
in MRS medium (Difco, Detroit, MI, USA) for 16 h at 
37 °C, washed with PBS, and heat killed (56 °C, 30 min). 
These bacterial samples were resuspended in DMEM, 
enumerated using a microscope and a Petroff-Hausser 
counting chamber, and stored at -80 °C until use (Shimazu 
et al., 2012; Villena et al., 2012).
Anti-inflammatory effect of lactobacilli in PIE cells
PIE cells were seeded at 3×104 cells per well in 12-well type 
I collagen-coated plates (Sumitomo Bakelite Co., Tokyo, 
Japan) and cultured for 3 days. After changing medium, 
lactobacilli (5×107 cells/ml) were added and 48 h later, each 
well was washed vigorously with medium at least three 
times to eliminate all stimulants. Then cells were stimulated 
with ETEC PAMPs (5×107 cells/ml) or LPS (1000 ng/ml; 
from E. coli O55:B5 prepared by phenol extraction followed 
by gel-filtration chromatography; Sigma, St. Louis, MO, 
USA) for 3, 6, 12, or 24 h for RT-PCR studies or for 12 h 
for microarray studies.
Microarray analysis
Total RNA was isolated from PIE cell sample using PureLink 
RNA Mini Kit (Life Technologies Inc. Gaithersburg 
MD, USA) and treated with DNase. RNA integrity of 
all samples were evaluated by Agilent 2100 Bioanalyzer 
(Agilent Technologies, Santa Clara, CA, USA), using the 
RNA 6000 Nano Kit. Complementary DNA synthesis, 
using 200 ng of RNA, and hybridisation with Porcine (V2) 
Gene Expression Microarray (Agilent Technologies) was 
performed at Hokkaido System Science Co. Scanning 
and digitisation of Microarray were done by Agilent 
Technologies Microarray Scanner and Agilent Feature 
Extraction 10.7.3.1, respectively. Data normalisation and 
expression analysis were performed with GeneSpring 
software version 13.1 (Agilent Technologies). Genes 
with significant changes in transcript abundance were 
selected on the basis of two criteria: a t-test P-value of less 
than 0.05, which was considered statistically significant, 
and a cut-off in transcript abundance of at least 2-fold. 
Statistical analysis was conducted with the Limma package 
from BioConductor in R software (version 3.2.5). Results 
were expressed as log2 scale (log2 ratio). Genes whose 
expressions were log2>1 and P<0.05 were annotated using 
‘Database for Annotation, Visualization, and integrated 
Discovery (DAVID), version 6.7 (https://david.ncifcrf.gov/), 
or GeneAnalytics (geneanalytics.genecards.org). Genes 
were further analysed according to Gene Ontology (GO) 
classification. Microarray data have been submitted to 
NCBI-GEO under the accession number GSE77095.
Quantitative expression analysis by RT-PCR
We performed two-step real-time quantitative PCR 
to characterise the expression of selected genes in PIE 
cells. Total RNA was isolated from each PIE cell sample 
using TRIzol reagent (Invitrogen). All cDNAs were 
synthesised using a Quantitect reverse transcription (RT) 
kit (Qiagen, Tokyo, Japan) according to the manufacturer’s 
recommendations. Real-time quantitative PCR was carried 
out using a 7300 real-time PCR system (Applied Biosystems, 
Warrington, UK) and the Platinum SYBR green qPCR 
SuperMix uracil-DNA glycosylase (UDG) with 6-carboxyl-
X-rhodamine (ROX) (Invitrogen). The primers used in 
this study are listed in Supplementary Table S1. The PCR 
cycling conditions were 2 min at 50 °C, followed by 2 min 
at 95 °C, and then 40 cycles of 15 s at 95 °C, 30 s at 60 °C, 
and 30 s at 72 °C. The reaction mixtures contained 5 μl of 
sample cDNA and 15 μl of master mix, which included the 
sense and antisense primers. Expression of β-actin was used 
to normalize cDNA levels for differences in total cDNA 
levels in the samples.
Statistical analysis
Statistical analyses were performed using GLM and REG 
procedures available in the SAS computer program (SAS, 
Cary, NC, USA). Comparisons between mean values were 
carried out using one-way ANOVA and Fisher’s least 
significant difference (LSD) test. For these analyses, P-values 
<0.05 were considered significant.
3. Results
Immunotranscriptomic changes in PIE cells after 
challenge with ETEC PAMPs
We first investigated the transcriptomic response of PIE 
cells to challenge with heat-stable ETEC PAMPs that is able 
to stimulate a potent inflammatory response in this cell line 
(Shimazu et al., 2012; Tomosada et al., 2013). Microarray 
analysis was performed using PIE cells 12 h after the 
stimulation with heat-stable ETEC PAMPs. When these 
cells were compared with unchallenged PIE cells we found 
that there were 3,095 transcripts (representing 715 unique 
genes) and 2,481 transcripts (representing 561 unique genes) 
up-regulated and down-regulated, respectively (Figure 1A, 
B). Out of these differentially regulated genes, several were 
assigned to immune related functions according to GO 
database (Figure 1C, Supplementary Table S2). Changes 
of immunotranscriptome response in PIE cells after heat-
stable ETEC PAMPs challenge included genes in the 
following GO Biological Process pathways: ‘innate immune 
response’, ‘inflammatory response’, ‘cytokine-mediated 
signalling pathway’, ‘cell adhesion’, ‘cell surface receptor 
signalling pathway’, and ‘blood coagulation’ among others 
(Figure 1C). Of interest, immune related genes were found 
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in the group of up-regulated genes, while no immune genes 
were detected in down-regulated transcripts.
The most remarkable changes in PIE cells after heat-stable 
ETEC PAMPs challenge were observed in expression of 
chemokines. The highest fold changes (log2 ratio) were 
observed for CXCL5 (9.2), CXCL10 (9.2), CXCL11 (9.1), 
CXCL9 (6.9), CSF2 (6.9), CCL4 (6.8), and CXCL8 (6.6) 
(Supplementary Table S2). Chemokines that are involved 
in neutrophils recruitment and activation such as CXCL5, 
CXCL11 and CXCL8 were up-regulated more than 6 folds 
(log2 ratio). In addition, we observed a significant up-
regulation of chemokines that are chemotactic factors 
for monocytes and T lymphocytes including CXCL10, 
CXCL9, CCL8, CCL20, CCL23, CX3CL1, and CXCL12 
(Supplementary Table S2). Moreover, chemokines involved 
in monocyte migration such as CCL2 were also increased.
Challenging PIE cells with ETEC PAMPs significantly 
increased the expression of inflammatory (TNF, IL-1α, 
IL-6, IL-18, and IL-25) and angiogenic (VEGFA) cytokines 
genes (Supplementary Table S2). Colony stimulating factor 
2 genes (CSF2) encoding a cytokine that is able to stimulate 
the growth and differentiation of hematopoietic precursor 
of granulocytes and macrophages was also significantly 
up-regulated.
In addition, we found the up-regulation of genes for 
adhesion molecules in PIE cells after stimulation with 
ETEC PAMPs including SELE, SELL, SELP, and ICAM-1 
(Supplementary Table S2). There was also a 6-fold increase 
in the expression of LGALS9 (galectin 9), which is involved 
in epithelial-lymphocytes interaction.
The microarray analysis revealed increases in the expression 
of several factors belonging to the complement system 
including C1R, C1S, C3, C8, CFB and CD46 (Supplementary 
Table S2). Interestingly, up-regulation of genes related 
to the coagulation cascade was also observed. The most 
remarkable effect was detected in tissue factor (F3) that 
was increased more than 4 folds (Supplementary Table S2). 
The expression of thrombin (F2), and fibrinogen (FGG) 
was increased as well.
Heat-stable  
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Inflammatory Response 
Type I Interferon Signaling Pathway 
Cytokine-mediated Signaling Pathway 
Response to Virus 
Defense Response to Virus 
Response to Lipopolysaccharide 
Immune Response 
Positive Regulation of ERK1 and ERK2 
Innate Immune Response 
Cellular Response to Lipopolysaccharide 
Chemokine-mediated Signaling Pathway 
Cellular Response to Interleukin-1 
Positive Regulation of Inflammatory 
Defense Response 
Interferon-gamma-mediated Signaling 
Blood Coagulation 
Chemotaxis 
Monocyte Chemotaxis 
Cellular Response to Interferon-gamma 
Leukocyte Migration 
Positive Regulation of NF-kappaB 
Eosinophil Chemotaxis 
Neutrophil Chemotaxis 
Cellular Response to Tumor Necrosis 
Negative Regulation of Inflammatory 
Positive Regulation of I-kappaB Kinase/
Response to Cytokine 
Cell Surface Receptor Signaling Pathway 
Lymphocyte Chemotaxis 
Lipopolysaccharide-mediated Signaling 
Cell Adhesion 
Positive Regulation of MAP Kinase 
Regulation of Inflammatory Response 
Regulation of Immune Response 
Toll-like Receptor 4 Signaling Pathway 
GO Biological Process 
Number of matched genes 
Figure 1. Differentially regulated genes in porcine intestinal epithelial (PIE) cells treated with Lactobacillus jensenii TL2937 or 
Lactobacillus plantarum TL2766 and challenged with heat-stable enterotoxigenic Escherichia coli (ETEC) pathogen-associated 
molecular patterns (PAMPs). Untreated PIE cells challenged with heat-stable ETEC PAMPs were used as controls. Venn diagrams 
showing the number of differentially up-regulated (A) and down-regulated (B) genes for each experimental group. Number of 
matched genes categorised according to gene Ontology (GO) database (C).
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Changes in the expression of two pattern recognition 
receptors were detected: TLR2 ,  and P GLYRP2 
(Supplementary Table S2). TLR4 expression was not 
modified in ETEC-challenged PIE cells. Gene expression 
of several factors binding to DNA and RNA from viruses 
involved in innate antiviral response was increased 
in PIE cells after heat-stable ETEC PAMPs challenge 
(Supplementary Table S2). In addition, expression of 
interferon (IFN)-β was increased 3-folds. Transcriptional 
regulators of type I IFN-dependent immune responses 
(IRF5 and IRF7) and signal transducers and transcription 
activators that mediate cellular responses to IFNs (STAT1 
and STAT2) were up-regulated in PIE cells after ETEC 
PAMPs stimulation (Supplementary Table S2).
A significant increase in the expression of NFκ polypeptide 
genes (NFKBIA, NFKB2, NFKB1) was detected in ETEC 
PAMPs-challenged PIE cells (Supplementary Table S2). We 
also detected increases in the expression of serum amyloid 
A2 (SAA2), and inducible nitric oxide synthase 2 (NOS2).
RT-PCR analysis of genes in PIE cells after challenge 
with ETEC PAMPs
To further evaluate the changes in gene expressions 
induced by heat-stable ETEC PAMPs in PIE cells, RT-
PCR was performed on the genes that showed significant 
up-regulation in the microarray profiles. From the 82 
immune and immune-related genes up-regulated by ETEC 
PAMPs (Figure 2, Supplementary Table S2, Figure S4) we 
selected 26 belonging to cytokines, chemokines, adhesion 
molecules, complement and coagulation factors, and SAA2 
to be studied by RT-PCR. We confirmed that the direction 
of the changes in gene expression was in agreement with 
results obtained in the microarray analysis in all the studied 
genes. We detected a significant increase in expression 
of CCL8, CXCL9 and CXCL11 with a peak at 12 h after 
ETEC PAMPs challenge (Figure 3). Similarly, we observed 
increases in expression of CCL4 and CXCL5 with peaks at 
3 h, and in CCL2, CCL5 and CSF2 with peaks at 24 h after 
the ETEC stimulation of PIE cells. In addition, expression of 
CCL20, CXCL2 and CXCL8 increased from 3 h and stayed 
in the same level during the complete studied period (Figure 
3). Stimulation of PIE cells with LPS also induced increases 
in all the studied chemokines, and the kinetic changes were 
similar to those observed in ETEC PAMPs-challenged 
PIE cells but with lower values. The only exception was 
CXCL8, which expression started to decrease after 12 h 
in LPS-stimulated PIE cells while it increased in ETEC 
PAMPs-challenged PIE cells (Figure 3).
Both, ETEC PAMPs and LPS increased the expression of 
IL-1α and IL-6. However, levels of both cytokines were 
lower in LPS-stimulated PIE cells when compared to those 
stimulated with ETEC PAMPs (Supplementary Figure S1). 
IFN-β was slightly up-regulated from 3 h after the challenge 
with ETEC or LPS with no differences between them 
(Supplementary Figure S1). Both, ETEC PAMPs and LPS 
increased the expression of SAA2 (Supplementary Figure 
S1), SELE, VCAM-1, and galectin 9 (Figure 4). However, 
expression levels of these transcripts were lower in LPS-
stimulated PIE cells when compared to those stimulated 
with ETEC PAMPs.
Stimulation of PIE cells with ETEC PAMPs or LPS induced 
an increase in gene expression of all the studied complement 
factors (C1R, C1S, C3 and CFB), which gradually increased 
until 24 h post-stimulation (Figure 4). In addition, 
coagulation factors F2 (thrombin) and F3 (tissue factor) 
were up-regulated after the challenges with ETEC PAMPs 
or LPS. F2 levels were similar with both stimuli; however 
expression of F3 was lower in LPS-treated PIE cells when 
compared to ETEC PAMPs-challenged cells (Figure 4).
Modulation of ETEC PAMPs-induced 
immunotranscriptome changes in PIE cells by L. jensenii
Next, we analysed microarray data to evaluate the effect 
of the immunobiotic L. jensenii TL2937 strain on the 
immunotranscriptomic response of PIE cells after the 
challenge with heat-stable ETEC PAMPs. For that purpose, 
PIE cells were stimulated with L. jensenii TL2937 or L. 
plantarum TL2766 (non-immunomodulatory strain), and 
then challenged with ETEC PAMPs. Comparative analysis 
of microarray profiles indicated that L. jensenii TL2937 
differentially modulated the expression of several genes 
6 
69 
2 0 
5 0 
0 
Heat-stable 
ETEC PAMPs   
L. jensenii TL2937 +
ETEC PAMPs
L. plantarum TL2766 + 
ETEC PAMPs  
Figure 2. Differentially regulated genes that are known to 
have immune related functions in porcine intestinal epithelial 
(PIE) cells treated with Lactobacillus jensenii TL2937 or 
Lactobacillus plantarum TL2766 and challenged with heat-stable 
enterotoxigenic Escherichia coli (ETEC) pathogen-associated 
molecular patterns (PAMPs). Untreated PIE cells challenged 
with heat-stable ETEC PAMPs were used as controls. Venn 
diagram showing the number of differentially up-regulated 
genes for each experimental group. 
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related to immune responses in PIE cells after the ETEC 
PAMPs stimulation (Supplementary Table S2).
The Venn diagram analysis was used to find genes that 
were uniquely and commonly modulated between 
lactobacilli-treated and control PIE cells (Figure 2). Of 
the 82 differentially expressed genes in the Venn diagram 
analysis, 6 were unique to the ETEC PAMPs challenge, while 
no unique genes were found in the TL2937 stimulation 
plus ETEC PAMPs challenge, or the TL2766 stimulation 
plus ETEC PAMPs challenge. In addition, 2 genes were 
common to TL2937 treatment plus ETEC PAMPs challenge 
and control, while 69 genes were common to all the three 
treatments. The cluster analysis in Supplementary Figure 
S4 depicts the transcriptomic patterns of differentially 
modulated genes between lactobacilli-treated and control 
PIE cells. The treatment with TL2766 plus ETEC PAMPs 
challenge clustered closer to the control than the treatment 
with TL2937 plus ETEC PAMPs.
Closer examination of the variations in gene expression 
induced by the immunobiotic strain TL2937 revealed 
differences in several up-regulated genes sheared with 
control PIE cells (Supplementary Table S2). Most remarkable 
differences were found in the genes belonging to cytokines 
and chemokines. Although expression of chemokines such 
as CXCL5, CXCL10, CXCL11, CXCL9, CCL8, CCL11 and 
CCL2 was up-regulated in TL2937-treated PIE cells after 
the challenge with ETEC PAMPs, the increases were 
significantly lower when compared to control PIE cells 
without lactobacilli treatment (Supplementary Table S2). 
Other chemokines such as CCL4, CCL5, CCL20, CXCL2, 
and CXCL8 were not different between TL2937-tretated 
and control ETEC PAMPs-challenged PIE cells. In addition, 
we observed that gene expression of the pro-inflammatory 
cytokines and chemokines TNF, CXCR6, and IL-25, which 
were up-regulated in the ETEC PAMPs-challenged control 
PIE cells, was not increased in cells treated with TL2937.
We also observed an increased expression of selectins 
(SELE, SELL, and SELP) genes in TL2937-treated PIE cells 
after the challenge with ETEC PAMPs when compared to 
the control cells, while galectin 9 (LGALS9) was diminished 
in TL2937-tretated cells (Supplementary Table S2). No 
significant differences were found in expression of other 
adhesion molecules such as VCAM-1 or ICAM-1.
Expression of TLR2 was up-regulated in TL2937-treated PIE 
cells after the challenge with ETEC PAMPs, however the 
increase was lower when compared to the control PIE cells 
without lactobacilli treatment (Supplementary Table S2). In 
addition, we observed that PGLYRP2 gene expression was 
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Figure 3. Expression of chemokines in porcine intestinal epithelial (PIE) cells after the challenge with heat-stable enterotoxigenic 
Escherichia coli (ETEC) pathogen-associated molecular patterns (PAMPs) or lipopolysaccharide (LPS), analysed by RT-PCR. The 
results represent data from three independent experiments.
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not affected in cells treated with TL2937 when compared 
to controls.
Although expression C1R, C1S, CFB, C3 and F3 (tissue 
factor) were up-regulated in TL2937-treated PIE cells 
after the challenge with ETEC PAMPs, the increase was 
significantly lower when compared to the control PIE cells 
without lactobacilli treatment (Supplementary Table S2). 
Interestingly, expression of F2 (thrombomodulin) was 
higher in immunobiotic treated cells than in ETEC PAMPs-
challenged control PIE cells.
Finally, we also detected that expression of SAA2 in TL2937-
treated PIE cells after the challenge with ETEC PAMPs 
was lower when compared to control PIE cells without 
lactobacilli treatment (Supplementary Table S2).
It should be noted that immunotranscriptomic response of 
PIE cells treated with the non-immunomodulatory strain 
L. plantarum TL2677 was almost identical to the response 
of ETEC PAMPs-challenged control PIE cells (Figure 2, 
Supplementary Table S2). The microarray data revealed 
differences only in the expression of SELE, SELP, SELL, 
and F2 genes, which were higher in TL2677-treated PIE 
cells than in control cells. In addition, the expression level 
of C5AR1, C8A, CD2, EGF, FGG, IL-25, TNF, IL-18RA, 
and LGALS9 genes in TL2766-treated PIE cells was lower 
than those observed in ETEC PAMPs-challenged control 
PIE cells.
RT-PCR analysis of genes in PIE cells challenged by 
ETEC PAMPs and stimulated by L. jensenii
In order to confirm the changes induced by TL2937 strain 
in the immunotranscriptome response of heat-stable ETEC 
PAMPs-challenged PIE cells, RT-PCR was performed on 
selected genes. Genes with or without significant differences 
between TL2937-tretated and non-treated PIE cells were 
chosen. The transcriptional changes evaluated by RT-
PCR indicated a similar overall trend in the transcription. 
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Figure 4. Expression of adhesion molecules and, complement and coagulation factors in porcine intestinal epithelial (PIE) cells 
after the challenge with heat-stable enterotoxigenic Escherichia coli (ETEC) pathogen-associated molecular patterns (PAMPs) or 
lipopolysaccharide (LPS), analysed by RT-PCR. The results represent data from three independent experiments.
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Expression of CCL4, CCL5, CCL20, CXCL2, CXCL8 and 
CSF2 in TL2937-treated PIE cells was not different from 
the control PIE cells after the challenge with heat-stable 
ETEC PAMPs (Supplementary Table S2). In contrast, levels 
of CCL2, CCL8, CXCL5, CXCL9, CXCL10 and CXCL11 were 
significantly lower in L. jensenii TL2937-tretaed PIE cells 
when compared to the controls (Figure 5). No differences in 
the expression profiles of chemokines were found between 
L. plantarum TL2677-treated PIE cells and control PIE cells 
after the challenge with ETEC PAMPs (Supplementary 
Figure S2, Figure 5).
In agreement with the results from our microarray analysis, 
both lactobacilli strains were able to increase the expression 
of selectin E (SELE) and reduce the expression of galectin 
9 (LGALS9), with no significant differences between them 
(Supplementary Figure S3). Moreover, no differences in 
VCAM-1 were found between lactobacilli-treated and 
control PIE cells.
Expression of IL-1α in TL2937- or TL2766-treated PIE 
cells was not different from the control PIE cells after the 
challenge with heat-stable ETEC PAMPs. In contrast, 
expression levels of IL-6 (Supplementary Figure S3) and 
SAA2 (Figure 6) were significantly lower in L. jensenii 
TL2937-tretaed PIE cells when compared to the controls.
We also observed that complement factors (C1R, C1S, C3 
and CFB) were significantly down-regulated in L. jensenii 
TL2937-tretaed PIE cells when compared to the controls 
(Figure 6). L. jensenii TL2937 significantly reduced the 
level of F3 in ETEC PAMPs-challenged PIE cells. Again, no 
differences in expression profiles of complement factors or 
F3 were found between L. plantarum TL2677-treated PIE 
cells and the control PIE cells after the challenge with ETEC 
PAMPs (Figure 6). Microarray data indicated a significant 
up-regulation of F2 by lactobacilli treatment, however RT-
PCR indicated no modification of the expression of F2 after 
bacterial treatments (Supplementary Figure S3). This was 
the only discrepancy between microarray and RT-PCR data.
4. Discussion
In the last decades, pig farms have significantly increased in 
size due to the growing food demand of human population. 
This fact has unfortunately increased the risk of diseases 
in those animals. Therefore, a better understanding of the 
immune system in the porcine host is essential, because 
susceptibility to infectious diseases has great influence 
on pig performance (Boddicker et al., 2013). Studies of 
transcriptomic pig immune response using whole porcine 
genome microarrays have enriched our knowledge of the 
pig immune system (Gao et al., 2010). In this regard, 
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Figure 5. Expression of chemokines in porcine intestinal epithelial (PIE) cells treated with Lactobacillus jensenii TL2937 or 
Lactobacillus plantarum TL2766 and challenged with heat-stable enterotoxigenic Escherichia coli (ETEC) pathogen-associated 
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controls. The results represent data from three independent experiments. Asterisks indicate significant differences (P<0.05).
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commercially available microarrays have been used to study 
pig immune responses against pathogens considering that 
gastrointestinal pathogens-associated diarrhoea results in 
morbidity and mortality in neonatal and weaned piglets, 
and is one of the economically most important diseases in 
swine husbandry.
High-throughput microarray technology has been employed 
for screening genes involved in disease processes or immune 
responses to pathogenic ETEC. Zhou et al. (2012) used 
the porcine IPEC-J2 cell line, originally derived from 
jejunal epithelia, for studying ETEC-IECs interactions 
and evaluating porcine transcriptional changes upon 
infection with three ETEC strains expressing different 
fimbriae (F4ab, F4ac and F18ac). The work found that 
2,443, 3,493 and 867 genes were differentially expressed 
in IPEC-J2 cells that after infection with F4ab, F4ac and 
F18ac ETEC, respectively. These results are in line with the 
knowledge that F4ac is the most common antigenic variant 
of F4 fimbriae causing piglet diarrhoea (Ji et al., 2010). In 
addition, the small intestinal segment perfusion technique 
and microarray analysis have been used to evaluate porcine 
early immune responses induced by different ETEC strains 
expressing heat-stable or heat-labile enterotoxins (Loos et 
al., 2012). Interestingly, most transcripts down-regulated 
by ETEC identified in that study were not associated with 
immune responses, while the immunomodulatory genes 
were abundant in the up-regulated transcripts.
Similarly, we demonstrated here that stimulation of PIE 
cells with heat-stable ETEC PAMPs significantly alters 
gene expression profiles. Of the transcripts differentially 
modulated by ETEC PAMPs challenge, 715 and 561 
unique genes were up-regulated and down-regulated, 
respectively. Moreover, the majority of genes associated 
with immune responses were present in the group of genes 
up-regulated after heat-stable ETEC PAMPs challenge. In 
fact, we found significant increases in the expression levels 
of cytokines, chemokines, and adhesion molecules genes in 
ETEC-stimulated PIE cells (Figure 7). Our findings are in 
agreement with previous studies. Geens and Niewold (2010) 
found genes differentially expressed between unchallenged 
IPEC-J2 cells and those stimulated with LPS or ETEC, 
including increases in CXCL2, IL-8, AREG and CYP1A1. In 
addition, the immune genes IL-8, LT-β, CXCL2, CCL20, and 
AMCF-II were highly up-regulated in IPEC-J2 cells upon 
F4ab, F4ac, or F18ac ETECs strains challenges (Zhou et al., 
2012). Collectively, these results show that ETEC stimulates 
a typical inflammatory response in porcine IECs, the extent 
of which is different according to the different ETEC strains, 
bacterial viability, and infection time.
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Figure 6. Expression of serum amyloid A2 (SAA2), complement and tissue factors in porcine intestinal epithelial (PIE) cells 
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ETEC adherence to IECs leads to NF-kB and MAPK 
pathway activation (Wang et al., 2012), and it has been 
shown in vitro that ETEC infection modulates the pro-
inflammatory responses through the regulation of NF-
kB and MAPK signalling pathways (Zanello et al., 2011). 
Moreover, in vivo studies in mice have found that the ETEC 
infection promotes intestinal expression of a set of pro-
inflammatory cytokines, including IL-1β, IL-6, TNF-α, 
IL-17, and IL-18, increases the expression of Rel and 
induces the phosphorylation of p38 and ERK1/2 proteins 
(Ren et al., 2014). We have previously demonstrated that 
stimulation of PIE cells with heat-stable ETEC PAMPs 
activates NF-kB and induces the phosphorylation of ERK, 
p38, and JNK leading to the production of CCL2 (MCP-1), 
CXCL8 (IL-8) and IL-6 (Shimazu et al., 2012). In the present 
work, we corroborated these findings by demonstrating 
that activation of NF-kB and MAPK pathways in PIE cells 
also increased the expression of several cytokines and 
chemokines including CCL4, CCL5, CCL8, CCL20, CXCL2, 
CXCL5, CXCL9, CXCL10, CXCL11, CSF2, and IL-1α by 
microarray analysis and RT-PCR. Moreover, some adhesion 
molecules were also significantly up-regulated in PIE cells 
after ETEC PAMPs stimulation including SELE, SELP, SELL, 
ICAM-1, and VCAM-1. These results indicate that PIE cells 
are able to mount a complex immune response involving 
changes needed to induce and promote the recruitment 
of inflammatory cells to the intestinal mucosa, which are 
intended to eliminate the pathogen. These features exhibit 
that PIE cells are an excellent laboratory tool to study 
treatments able to favourably modulate the inflammatory 
response.
In addition to cytokines and adhesion molecules, we also 
observed variations in other immune related genes in PIE 
cells after the challenge with ETEC PAMPs including PRRs, 
and complement and coagulation factors (Figure 7).
Challenge of PIE cells with ETEC PAMPs did not change 
the expression of TLR4. Loos et al. (2012) showed no 
differential regulation of TLR4 gene in porcine intestinal 
segments infected with ETEC strain. This last report 
was in agreement with a microarray study in IPEC-J2 
cells showing no induction of TLR4 after co-incubation 
with ETEC compared to mock-infected cells (Geens and 
Niewold, 2010). Therefore, it seems that ETEC does not 
induce significant changes in TLR4 expression in porcine 
IECs. In contrast, ETEC PAMPs significantly up-regulated 
the expression of two PRRs in PIE cells: TLR2 and PGLYRP2 
genes. This is in agreement with previous reports that have 
demonstrated that PGYRP2 gene was highly up-regulated in 
IPEC-J2 cells after the challenge with ETEC strains (Zhou 
et al., 2012).
The humoral innate immune system is comprised of soluble 
plasma components that include complement, acute phase 
proteins, and antimicrobial peptides (Shishido et al., 2012). 
Acute phase proteins are blood proteins that are rapidly 
induced in response to inflammation caused by tissue injury, 
infections or stress. The major acute phase proteins in 
pigs are C-reactive protein, pig-MAP, haptoglobin, and 
serum amyloid A (SAA2) (Mair et al., 2014). On the other 
hand, the complement cascade is activated through three 
independent pathways using several membrane-anchored, 
and soluble proteins that together constitute a proteolytic 
cascade (Shishido et al., 2012). These processes result 
in the formation of the membrane attack complex that 
lyses host or pathogenic cells by formation of pores in the 
cellular membrane. Downstream of the multiple routes 
to complement activation, the generation of C3 and C5 
convertases is a key reaction leading to the production of 
C3a and C5a, which are potent inflammatory mediators. 
It has been demonstrated that three IECs lines (T84, 
Caco2, and HT29) express mRNA for complement 
glycoproteins (Cao et al., 2012). Those studies were 
consistent with reports of C4 expression at the protein 
level in T84 and Caco2, and factor B detected in Caco2 cell 
culture supernatants, confirming that IECs are a source 
of complement in the gut (Bernet-Camard et al., 1996). 
Moreover, it was found that IECs express C5aR apically and 
directly respond to C5a through ERK signalling pathway 
with responses that promote inflammation (Cao et al., 
2012). Recent studies on the role of complement proteins 
during enteric infections have showed that this innate 
defence mechanism is important for the protection of mice 
against Citrobacter rodentium, which is an attaching and 
effacing mouse pathogen that models enteropathogenic 
and enterohemorrhagic E. coli in humans (Jain et al., 
2015). The authors showed that properdin knockout mice 
had increased diarrhoea and exacerbated inflammation 
combined with defective epithelial cell-derived IL-6 and 
greater numbers of colonising bacteria. Those effects were 
related to a failure to increase local C5a levels. In the current 
study, we detected significant increases in the expression of 
SAA2 and several components of the complement system 
including C1R, C1S, C3, CFB, and C5AR1 in PIE cells after 
the challenge with ETEC PAMPs, indicating that these 
factors may have an important role in the inflammatory 
response induced by ETEC infection in the porcine host.
We observed a significant increase in the expression of 
some factors of the coagulation system in PIE cells treated 
with ETEC PAMPs, especially in tissue factor (TF, F3 gene) 
expression. TF is the membrane receptor that initiates the 
extrinsic coagulation pathway. TF also plays an important 
role in inflammatory processes. Queiroz et al. (2011) 
evaluated whether ablation of TF reduced experimental 
colitis by using wild-type and TF-deficient mice treated 
with dextran sulfate sodium. The work demonstrated 
that the severity of colitis was diminished in TF-deficient 
mice compared with controls. Most notably, neutrophils 
infiltration at the site of inflammation, and cytokine levels 
were reduced in TF-deficient mice. It was shown that TF 
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induced high levels of the granulocyte-chemoattractant 
chemokine KC in the colon, thereby stimulating neutrophils 
influx with subsequent inflammatory-induced organ 
damage. Based on these findings, the increase in the TF 
expression observed in our current study allows us to 
speculate that coagulation system activation would also 
contribute to the activation of the inflammatory response 
induced by ETEC infection in pigs.
Several studies have shown that immunobiotics are able 
to beneficially modulate PRRs-mediated inflammatory 
response in the gut by modulating the functions of IECs 
(Villena and Kitazawa, 2014). In this regard, we selected 
lactobacilli strains with the capacity to regulate the 
inflammatory response induced by ETEC and LPS in 
PIE cells by evaluating the levels of IL-1α, IL-6, IL-8, and 
MCP-1 (Shimazu et al., 2012). We found that IL-6 and 
IL-8 levels in PIE cells stimulated with some lactobacilli 
strains, especially L. jensenii TL2937, were significantly 
lower than those in control cells. Moreover, L. jensenii 
TL2937 have been shown to inhibit NF-κB and MAPK 
signalling pathways in ETEC- and LPS-challenged PIE cells 
through an up-regulation of the expression of the negative 
TLR regulators MKP-1, A20, and Bcl-3 (Shimazu et al., 
2012). In the present work, the treatment of PIE cells with 
L. jensenii TL2937 also resulted in differential expression 
of several pro-inflammatory mediators in response to the 
ETEC PAMPs challenge. Most notable changes were found 
in chemokines, since expression levels of CCL2, CCL8, 
CXCL5, CXCL9, CXCL10, and CXCL11 were significantly 
lower in TL2937-treated PIE cells when compared to the 
controls (Figure 7). This finding is of interest because it not 
only confirms our previous in vitro (Shimazu et al., 2012; 
Tsukida et al., 2016; Villena et al., 2012) and in vivo (Suda 
et al., 2014) studies demonstrating the anti-inflammatory 
capacity of L. jensenii TL2937, but also provides a potential 
set of biomarkers for the screening and selection of new 
immunoregulatory bacterial strains.
Of note, L. jensenii TL2937 also induced a differential 
expression of adhesion molecules in ETEC PAMPs-
challenged PIE cells; however, the same effect was 
obtained with the negative control strain L. plantarum 
TL2677. Therefore, adhesion molecules such as SELE or 
LGALS9 would not have an application as biomarkers for 
immunobiotics’ selection.
Interestingly, L. jensenii TL2937 was able to modify the 
expression of acute phase proteins and factors from the 
complement and coagulation system in PIE cells after the 
challenge with ETEC PAMPs (Figure 7). This is in line with 
our previous in vivo experiments using piglets of 3 weeks 
of age, which demonstrated that feeding with L. jensenii 
TL2937 significantly reduced blood complement activity 
and C reactive protein concentrations (Suda et al., 2014). 
Moreover, using gene expression profiling microarrays, 
Bao et al. (2011) have analysed and screened porcine 
genes conferring resistance against ETEC infection by 
comparing responses of ETEC-resistant and ETEC-sensitive 
pig populations. The authors showed that transcriptomic 
differences between sensitive and resistant pigs included 
genes of complement and coagulation factors, although 
these genes have not been studied in detail or validated 
by RT-PCR. Then, similarly to cytokines and chemokines, 
down-regulation of acute phase proteins, complement, and 
coagulation factors by the immunobiotic TL2937 strain 
would be beneficial to modulate the inflammatory response 
and protect against the infection-induced intestinal damage. 
This is in agreement with the knowledge that complement 
is essential for the induction of TF expression upon E. 
coli stimulation, having both systems an important role 
in inflammation and sepsis (Brekke et al., 2013). It has 
been reported that the inhibition of complement inhibits 
the E. coli-induced inflammatory response in blood cells 
by reducing the production of pro-inflammatory factors 
including cytokines (TNF-α, IL-6, INF-γ, and IL-1β), 
chemokines (IL-8, MCP-1, MIP-1α, MIP-1β, eotaxin, 
and IP-10), growth factors (VEGF, G-CSF, and GM-CSF) 
(Brekke et al., 2008) and TF up-regulation and coagulation 
activation (Landsem et al., 2013).
It was also reported that gut commensal microorganisms 
promote TF glycosylation, coagulation proteases activation, 
and phosphorylation of the cytoplasmic domain of TF in the 
small intestine (Reinhardt et al., 2012). Moreover, the work 
demonstrated that the microbiota-induced extravascular 
TF-PAR1 signalling, and influenced vascular remodelling 
in the small intestine. These findings indicate that intestinal 
microorganisms are able to modulate the function of 
coagulation factors in the intestine. Some works have also 
demonstrated the capacity of immunobiotic bacteria to 
beneficially modulate the interaction between inflammation 
and coagulation during infections. Our previous studies 
performed with the immunobiotic strain Lactobacillus 
rhamnosus CRL1505 clearly demonstrated that the probiotic 
bacterium is able to influence lung immune-coagulative 
reaction triggered by TLR3 activation, by modulating the 
production of pro-inflammatory and anti-inflammatory 
cytokines as well as expression of TF and thrombomodulin 
in the lung (Zelaya et al., 2014, 2015). This beneficial effect 
induced by the CRL1505 strain allows the reduction of 
lung tissue damage induced by respiratory syncytial virus 
(Zelaya et al., 2014) or influenza virus (Zelaya et al., 2015). 
In addition, the effect of probiotic bacteria on complement 
system gene expression in IECs has been described before. 
Studies in the cell line HT29 showed that Bifidobacterium 
breve IPLA20004 significantly up-regulated the expression 
of the complement component C3 and suggested that this 
effect could favor the recruitment of innate immune cells 
to the mucosa reinforcing the intestinal barrier (Sánchez 
et al., 2015). To our knowledge, no study has described 
a beneficial effect of an immunobiotic bacterium on 
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complement and coagulation factors expression during 
ETEC-induced inflammation. Future investigation is 
necessary for understanding the beneficial effect of 
immunobiotic bacterium on these factors during ETEC 
infection in the porcine host.
In conclusion, the transcriptomic study performed in 
this work allowed us to obtain a global overview of the 
expression patterns of immune and immune-related 
genes involved in response of PIE cells to heat-stable 
ETEC PAMPs. The present study also confirmed that L. 
jensenii TL2937 differently modulates gene expression 
in ETEC PAMPs-challenged PIE cells. The microarray 
transcriptomic profiles and gene expression patterns 
studied by RT-PCR simultaneously demonstrated that an 
anti-inflammatory effect was triggered by the immunobiotic 
strain in PIE cells. The main outcome from the study was 
the differential regulation of chemokines, complement, 
and coagulation factors expression by L. jensenii TL2937. 
These results provided clues for the better understanding 
the mechanism underlying host-immunobiotic interaction 
in the porcine host. Moreover, our transcriptomic analysis 
successfully identified a group of genes (CCL8, CXCL5, 
CXCL9, CXCL10, CXCL11, C1R, C1S, C3, CFB, F3, and 
SAA2), which can be used as prospective biomarkers for 
the screening of new anti-inflammatory immunobiotics 
in PIE cells.
Supplementary material
Supplementary material can be found online at http://
dx.doi.org/10.3920/BM2016.0095.
Figure S1. Expression of cytokines and serum amyloid 
A2 in porcine intestinal epithelial cells after the challenge 
with heat-stable enterotoxigenic Escherichia coli pathogen-
associated molecular patterns or lipopolysaccharide.
Figure S2. Expression of chemokines in porcine intestinal 
epithelial cells treated with Lactobacillus jensenii TL2937 or 
Lactobacillus plantarum TL2766 and challenged with heat-
stable enterotoxigenic Escherichia coli pathogen-associated 
molecular patterns.
Figure S3. Expression of cytokines, thrombin, and adhesion 
molecules in porcine intestinal epithelial cells treated with 
Lactobacillus jensenii TL2937 or Lactobacillus plantarum 
TL2766 and challenged with heat-stable enterotoxigenic 
Escherichia coli pathogen-associated molecular patterns.
Figure S4. Heat map analysis of differentially regulated 
genes that are known to have immune related functions in 
porcine intestinal epithelial cells treated with Lactobacillus 
jensenii TL2937 or Lactobacillus plantarum TL2766 and 
challenged with heat-stable enterotoxigenic Escherichia 
coli pathogen-associated molecular patterns. 
Table S1. Primers sequences used in RT-PCR studies.
Table S2. Transcripts in porcine intestinal epithelial cells 
treated with Lactobacillus jensenii TL2937 or Lactobacillus 
plantarum TL2766 and challenged with heat-stable 
enterotoxigenic Escherichia coli pathogen-associated 
molecular patterns.
Acknowledgements
This study was supported by a Grant-in-Aid for Scientific 
Research (B) (2) (No.24380146, 16H05019), Challenging 
Exploratory Research (No. 23658216, 26660216, 16 K15028) 
and Open Partnership Joint Projects of JSPS Bilateral Joint 
Research Projects from the Japan Society for the Promotion 
of Science (JSPS) to Dr. H. Kitazawa. Dr. P. Kanmani and 
Dr. A.K.M.H. Kober were supported by JSPS (Postdoctoral 
Fellowship for Foreign Researchers, Program No. 25-03397 
and No. 15 F15401, respectively).
References
Bao, W.B., Ye, L., Pan, Z.Y., Zhu, J., Du, Z.D., Zhu, G.Q., Huang, 
X.G. and Wu, S.L., 2011. Microarray analysis of differential gene 
expression in sensitive and resistant pig to Escherichia coli F18. 
Animal Genetics 43: 525-534.
Bernet-Camard, M., Coconnier, M., Hudault, S. and Servin, A., 1996. 
Differential expression of complement proteins and regulatory decay 
accelerating factor in relation to differentiation of cultured human 
colon adenocarcinoma cell lines. Gut 38: 248-253.
Boddicker, N.J., Garrick, D.J., Rowland, R.R., Lunney, J.K., Reecy, J.M. 
and Dekkers, J.C., 2013. Validation and further characterization of 
a major quantitative trait locus associated with host response to 
experimental infection with porcine reproductive and respiratory 
syndrome virus. Animal Genetics 45: 48-58.
Brekke, O.L., Christiansen, D., Fure, H., Pharo, A., Fung, M., Riesenfeld, 
J. and Mollnes, T.E., 2008. Combined inhibition of complement and 
CD14 abolish E. coli-induced cytokine-, chemokine- and growth 
factor-synthesis in human whole blood. Molecular Immunology 
45: 3804-3813.
Brekke, O.L., Waage, C., Christiansen, D., Fure, H., Qu, H., Lambris, 
J.D., Østerud, B., Nielsen, E.W. and Mollnes, T.E., 2013. The effects 
of selective complement and CD14 inhibition on the E. coli-induced 
tissue factor mRNA upregulation, monocyte tissue factor expression, 
and tissue factor functional activity in human whole blood. Advances 
in Experimental Medicine and Biology 735: 123-136.
Cao, Q., McIsaac, S.M. and Stadnyk, A.W., 2012. Human colonic 
epithelial cells detect and respond to C5a via apically expressed 
C5aR through the ERK pathway. American Journal of Physiology 
– Cell Physiology 302: C1731-C1740.
Gao, Y., Flori, L., Lecardonnel, J., Esquerre, D., Hu Z.L., Teillaud, A., 
Lemonnier, G., Lefevre, F., Oswald, I.P. and Rogel-Gaillard, C., 2010. 
Transcriptome analysis of porcine PBMCs after in vitro stimulation 
by LPS or PMA/ionomycin using an expression array targeting the 
pig immune response. BMC Genomics 11: 292.
ht
tp
://
w
w
w
.w
ag
en
in
ge
na
ca
de
m
ic
.c
om
/d
oi
/p
df
/1
0.
39
20
/B
M
20
16
.0
09
5 
- W
ed
ne
sd
ay
, N
ov
em
be
r 3
0,
 2
01
6 
3:
01
:3
4 
A
M
 - 
IP
 A
dd
re
ss
:1
81
.1
11
.4
3.
16
4 
H. Kobayashi et al.
782 Beneficial Microbes 7(5)
Geens, M.M. and Niewold, T.A., 2010. Preliminary characterization 
of the transcriptional response of the porcine intestinal cell line 
IPEC-J2 to enterotoxigenic Escherichia coli, Escherichia coli, and 
E. coli lipopolysaccharide. Comparative and Functional Genomics 
2010: 469583.
Jain, U., Cao, Q., Thomas, N.A., Woodruff, T.M., Schwaeble, W.J., 
Stover, C.M., Stadnyk, A.W., 2015. Properdin provides protection 
from Citrobacter rodentium-induced intestinal inflammation in a 
C5a/IL-6-dependent manner. Journal of Immunology 194: 3414-3421.
Ji, H., Ren, J., Yan, X., Huang, X., Zhang, B., Zhang, Z. and Huang, L., 
2010. The porcine MUC20 gene: molecular characterization and 
its association with susceptibility to enterotoxigenic Escherichia 
coli F4ab/ac. Molecular Biology Reports 38: 1593-1601.
Landsem, A., Nielsen, E.W., Fure, H., Christiansen, D., Ludviksen, J.K., 
Lambris, J.D., Østerud, B., Mollnes, T.E. and Brekke, O.L., 2013. 
C1-inhibitor efficiently inhibits Escherichia coli-induced tissue 
factor mRNA up-regulation, monocyte tissue factor expression 
and coagulation activation in human whole blood. Clinical and 
Experimental Immunology 173: 217-219.
Loos, M., Geens, M., Schauvliege, S., Gasthuys, F., Van der Meulen, 
J. and Dubreuil, J.D., 2012. Role of heat-stable enterotoxins in the 
induction of early immune responses in piglets after infection with 
enterotoxigenic Escherichia coli. PLoS One 7: e41041.
Mair, K.H., Sedlak, C., Käser, T., Pasternak, A., Levast, B., Gerner, 
W., Saalmüller, A., Summerfield, A., Gerdts, V., Wilson, H.L. and 
Meurens, F., 2014. The porcine innate immune system: an update. 
Developmental and Comparative Immunology 45: 321-343.
Moue, M., Tohno, M., Shimazu, T., Kido, T., Aso, H., Saito, T. and 
Kitazawa, H., 2008. Toll-like receptor 4 and cytokine expression 
involved in functional immune response in an originally established 
porcine intestinal epitheliocyte cell line. Biochimica et Biophysica 
Acta 1780: 134-144.
Ondrackova, P., Alexa, P., Matiasovic, P., Volf, J. and Faldyna, M., 
2012. Interaction of porcine neutrophils with different strains 
of enterotoxigenic Escherichia coli. Veterinary Microbiology 
60: 108-116.
Queiroz, K.C.S., Van ’t Veer, C., Van den Berg, Y., Duitman, J., 
Versteeg, H.H., Aberson, H.L., Groot, A.P., Verstege, M.I., Roelofs, 
J.J., Te Velde, A.A. and Spek, C.A., 2011. Tissue factor-dependent 
chemokine production aggravates experimental colitis. Molecular 
Medicine 17: 1119-1126.
Reinhardt, C., Bergentall, M., Greiner, T.U., Schaffner, F., Ostergren-
Lundén, G., Petersen, L.C., Ruf, W. and Bäckhed, F., 2012. Tissue 
factor and PAR1 promote microbiota-induced intestinal vascular 
remodelling. Nature 483: 627-631.
Ren, W., Yin, J., Duan, J., Liu, G., Zhu, X., Chen, S., Li, T., Wang, S. 
and Tang, Y., 2014. Hardwidge PR. Mouse intestinal innate immune 
responses altered by enterotoxigenic Escherichia coli (ETEC) 
infection. Microbes and Infection 16: 954-961.
Sánchez, B., González-Rodríguez, I., Arboleya, S., López, P., Suárez, 
A., Ruas-Madiedo, P., Margolles, A. and Gueimonde, M., 2015. 
The effects of Bifidobacterium breve on immune mediators and 
proteome of HT29 cells monolayers. BioMed Research International 
2015: 479140.
Schroyen, M. and Tuggle, C.K., 2015. Current transcriptomics in pig 
immunity research. Mammalian Genome 26: 1-20.
Shimazu, T., Villena, J., Tohno, M., Fujie, H., Hosoya, S., Shimosato, T., 
Aso, H., Suda, Y., Kawai, Y., Saito, T., Makino, S., Ikegami, S., Itoh, H. 
and Kitazawa, H., 2012. Immunobiotic Lactobacillus jensenii elicit 
anti-inflammatory activity in porcine intestinal epithelial cells by 
modulating negative regulators of the toll-like receptor signalling 
pathway. Infection and Immunity 80: 276-288.
Shishido, S.N., Varahan, S., Yuan, K., Li, X. and Fleming, S.D., 2012. 
Humoral innate immune response and disease. Clinical Immunology 
144: 142-158.
Suda, Y., Villena, J., Takahashi, Y., Hosoya, S., Tomosada, Y., Tsukida, 
K., Shimazu, T., Aso, H., Tohno, M., Ishida, M., Makino, S., Ikegami, 
S. and Kitazawa, H., 2014. Immunobiotic Lactobacillus jensenii as 
immune-health promoting factor to improve growth performance 
and productivity in post-weaning pigs. BMC Immunology 14: 24.
Tomosada, Y., Villena, J., Murata, K., Chiba, E., Shimazu, T., Aso, 
H., Iwabuchi, N., Xiao, J., Saito, T. and Kitazawa, H., 2013. 
Immunoregulatory effect of Bifidobacteria strains in porcine 
intestinal epithelial cells through modulation of ubiquitin-editing 
enzyme A20 expression. PLoS One 8: e59259.
Tsukida, K., Takahashi, T., Iida, H., Kanmani, P., Suda, Y., Nochi, T., 
Ohwada, S., Aso, H., Ohkawara, S., Makino, S., Kano, H., Saito, 
T., Villena, J. and Kitazawa, H., 2016. Immunoregulatory effects 
triggered by immunobiotic Lactobacillus jensenii TL2937 strain 
involve efficient phagocytosis in porcine antigen presenting cells. 
BMC Immunology 17: 21.
Villena, J. and Kitazawa, H., 2014. Modulation of intestinal TLR4-
inflammatory signalling pathways by probiotic microorganisms: 
lessons learned from Lactobacillus jensenii TL2937. Frontiers in 
Immunology (Frontiers in Immunological Tolerance) 4: 1-12.
Villena, J., Suzuki, R., Fujie, H., Chiba, E., Takahashi, T., Shimazu, 
T., Aso, H., Ohwada, S., Suda, Y., Ikegami, S., Itoh, H., Alvarez, S., 
Saito, T. and Kitazawa H., 2012. Immunobiotic Lactobacillus jensenii 
modulates toll-like receptor 4-induced inflammatory response. 
Clinical and Vaccine Immunology 19: 1038-1053.
Wang, X. and Hardwidge, P.R., 2012. Enterotoxigenic Escherichia coli 
prevents host NF-kappaB activation by targeting I kappa B alpha 
polyubiquitination. Infection and Immunity 80: 4417-4425.
Zanello, G., Berri, M., Dupont, J., Sizaret, P.Y., D’Inca, R., Salmon, H. 
and Meurens, F., 2011. Saccharomyces cerevisiae modulates immune 
gene expressions and inhibits ETEC-mediated ERK1/2 and p38 
signaling pathways in intestinal epithelial cells. PLoS One 6: e18573.
Zelaya, H., Tada, A., Vizoso-Pinto, M.G., Salva, S., Kanmani, P., Agüero, 
G., Alvarez, S., Kitazawa, H. and Villena, J., 2015. Nasal priming with 
immunobiotic Lactobacillus rhamnosus modulates inflammation-
coagulation interactions and reduces influenza virus-associated 
pulmonary damage. Inflammation Research 64: 589-602.
Zelaya, H., Tsukida, K., Chiba, E., Marranzino, G., Alvarez, S., 
Kitazawa, H., Agüero, G. and Villena, J., 2014. Immunobiotic 
lactobacilli reduce viral-associated pulmonary damage through the 
modulation of inflammation-coagulation interactions. International 
Immunopharmacology 19: 161-173.
Zhou, C., Liu, Z., Jiang, J., Yu, Y. and Zhang, Q., 2012. Differential gene 
expression profiling of porcine epithelial cells infected with three 
enterotoxigenic Escherichia coli strains. BMC Genomics 13: 330.
ht
tp
://
w
w
w
.w
ag
en
in
ge
na
ca
de
m
ic
.c
om
/d
oi
/p
df
/1
0.
39
20
/B
M
20
16
.0
09
5 
- W
ed
ne
sd
ay
, N
ov
em
be
r 3
0,
 2
01
6 
3:
01
:3
4 
A
M
 - 
IP
 A
dd
re
ss
:1
81
.1
11
.4
3.
16
4 
